- News
SRI International has announced that it has been awarded a $49 million, seven-year contract with NIH-subsidiary the National Institute of Allergy and Infectious Diseases, to conduct preclinical development of HIV infection and AIDS therapies. The contract will support investigation into drug development and treatment of HIV and AIDS, as well as providing preventive techniques of sexually […] More